{ "ok": true, "cik": "1932393", "ticker": "GEHC", "name": "GE HEALTHCARE TECHNOLOGIES INC.", "filings": [ { "form": "8-K", "filed": "2026-09-22", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1932393/000193239326000053/0001932393-26-000053-index.htm" }, { "form": "8-K", "filed": "2026-08-18", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1932393/000193239326000050/0001932393-26-000050-index.htm" }, { "form": "8-K", "filed": "2026-07-29", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1932393/000193239326000047/0001932393-26-000047-index.htm" }, { "form": "10-Q", "filed": "2026-07-29", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1932393/000193239326000046/0001932393-26-000046-index.htm" }, { "form": "8-K", "filed": "2026-07-29", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1932393/000193239326000045/0001932393-26-000045-index.htm" }, { "form": "8-K", "filed": "2026-07-23", "items": [ "2.02 Results of Operations and Financial Condition", "5.02 Departure or Election of Directors; Appointment of Officers", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1932393/000193239326000039/0001932393-26-000039-index.htm" } ], "events12m": 13, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001932393.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1932393" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up GE HEALTHCARE TECHNOLOGIES INC. ($GEHC). Last filing: 8-K (5.02 Departure or Election of Directors; Appointment of Officers), 2026-09-22. 13 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 20625000000, "revenueGrowth1y": 0.048444489629930976, "revenueGrowthPerYear": 0.04066966706760278, "yearsOfData": 5, "operatingMargin": 0.13396363636363637, "operatingMarginPrior": 0.13343838958926393, "netMargin": 0.10443636363636363, "operatingCashFlow": null, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": 1260000000, "researchShareOfRevenue": 0.06109090909090909, "cash": 4492000000, "longTermDebt": 10003000000, "longTermDebtChange": 0.11752876773544862, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 17585000000 }, { "fiscalYearEnd": "2022-12-31", "revenue": 18341000000 }, { "fiscalYearEnd": "2023-12-31", "revenue": 19552000000 }, { "fiscalYearEnd": "2024-12-31", "revenue": 19672000000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 20625000000 } ], "totalEquity": 10379000000, "totalAssets": 36906000000, "equityRatio": 0.28122798460954856, "returnOnEquity": 0.20753444455149822, "dividendsPaid": 64000000, "payoutRatio": 0.029712163416898793, "dividendPerShare": 0.14, "dividendYearsRising": 2, "dividendCut": false, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": 4.56, "sharesOutstanding": 458000000, "bookValuePerShare": 22.66157205240175, "revenuePerShare": 45.032751091703055, "range80": { "low": 17022071289.537027, "high": 24426155435.972797, "baseline": 21536021368.34138, "n": 1471, "band": "b10" }, "ifPaceHeld": { "low": 17022071289.537027, "high": 24426155435.972797 } }, "edgarette": "🔖 Exposure: revenue $20.6B (FY2025), total debt $10.0B. Experience: revenue up 4.8% on the year, up 4.1% a year over 4 years; operating margin 13.4%, up from 13.3%. Soundness: equity 28.1% of assets, return on equity 20.8%, payout 3.0% of profit, dividend per share up 2 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $17.0B and $24.4B next year (method v3, set from 1,471 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (90 filers, $50M+ revenue, its industry group): operating margin 13.4% against a 3.7% median; growth 4.8% against 9.9%.", "peers": { "sic": 3844, "sicDescription": "X-Ray Apparatus & Tubes & Related Irradiation Apparatus", "calendarYear": 2025, "minRevenue": 50000000, "depth": 3, "group": "384", "growth": [ 0.0986, 91 ], "opMargin": [ 0.0368, 90 ], "equityRatio": [ 0.5291, 89 ], "returnOnEquity": [ 0, 85 ], "payoutRatio": [ 0.35, 15 ] }, "summary": "Ge Healthcare Technologies (GEHC) grew revenue 4.8% in FY2025 to $20.6 billion, operating margin 13.4% against a 3.7% median for x-ray apparatus & tubes & related irradiation apparatus, equity 28.1% of assets, and dividend per share up 2 years running. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
GE HEALTHCARE TECHNOLOGIES INC. against its own record and its peers
Operating marginPeer median 3.7%13.4%Revenue, on the yearPeer median 9.9%4.8%Equity of assetsPeer median 52.9%28.1%Return on equityPeer median 0.0%20.8%Payout of profitPeer median 35.0%3.0%Gold tick: the median of 15–89 peers with $50M+ revenue in x-ray apparatus & tubes & related irradiation apparatus
", "chartHorizon": "
Handed back now, or kept to compound
Of each dollar of profit3.0% paid out97.0% keptHanded back per share$0.14up 2 years runningGrowth its own profit can fund20.1%retained x return on equityRevenue growth it managed4.8%last year, for comparison

Gold is paid out to shareholders; navy is kept in the business. Retained profit times return on equity is the pace a company can fund from itself. Facts from the filings, not a recommendation.

", "backtest": { "tests": 1, "hits": 1, "rate": 1, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-23T14:36:55.601Z", "hash": "7b9eea2295ac7c3c", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Ge Healthcare Technologies (GEHC) grew revenue 4.8% in FY2025 to $20.6 billion, operating margin 13.4% against a 3.7% median for x-ray apparatus & tubes & related irradiation apparatus, equity 28.1% of assets, and dividend per share up 2 years running. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 20625000000, "totalDebt": 10003000000, "cash": 4492000000 }, "experience": { "revenueGrowth1y": 0.048444489629930976, "revenueGrowthPerYear": 0.04066966706760278, "operatingMargin": 0.13396363636363637, "operatingMarginPrior": 0.13343838958926393, "netMargin": 0.10443636363636363, "freeCashFlow": null }, "soundness": { "equityRatio": 0.28122798460954856, "returnOnEquity": 0.20753444455149822, "payoutRatio": 0.029712163416898793, "dividendPerShare": 0.14, "dividendYearsRising": 2, "dividendCut": false, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 3844, "sicDescription": "X-Ray Apparatus & Tubes & Related Irradiation Apparatus", "calendarYear": 2025, "minRevenue": 50000000, "depth": 3, "group": "384", "growth": [ 0.0986, 91 ], "opMargin": [ 0.0368, 90 ], "equityRatio": [ 0.5291, 89 ], "returnOnEquity": [ 0, 85 ], "payoutRatio": [ 0.35, 15 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "range": { "low": 17022071289.537027, "high": 24426155435.972797, "baseline": 21536021368.34138, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 1471, "sizeBand": "b10" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 1, "hits": 1, "rate": 1, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-23T14:36:55.601Z", "hash": "7b9eea2295ac7c3c", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001932393.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1932393" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }